GSK and Moderna Settle Patent Fight Over COVID and RSV Shots

GSK and Moderna settled all patent suits over Spikevax, mNEXSPIKE and mResvia, swapping cross-licenses with no payments. GSK's parallel case against Pfizer and BioNTech continues.